Added to YB: 2025-10-29
Pitch date: 2025-10-26
MYX.AX [bullish]
Mayne Pharma Group Limited
-47.5%
current return
Author Info
Halvio Capital is an investment firm that seeks to compound capital at high rates of return while taking limited risk of capital impairment through separately managed accounts. The firm’s goal is to outperform the broader indices over a long time frame. Sign up for the newsletter.
Company Info
Mayne Pharma Group Limited, a specialty pharmaceutical company, focuses on the commercialization of women’s health and dermatology pharmaceuticals in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally.
Market Cap
AUD 501.3M
Pitch Price
AUD 6.19
Price Target
7.40 (+128%)
Dividend
N/A
EV/EBITDA
9.68
P/E
-5.41
EV/Sales
1.08
Sector
Pharmaceuticals
Category
special_situation
Mayne Merger Arb Opportunity
MYX.AX (merger arb): Mayne-Cosette merger arb at ~20% spread ($6.17 vs $7.40 cash deal). Court ruled for Mayne on Oct 15 after Cosette's bogus MAC claims. Two hurdles remain: FIRB approval by Oct 31 (Cosette threatens plant closure as exit ploy) & potential appeal by Nov 12. High probability close but sized small due to asymmetric downside risk.
Read full article (4 min)